Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009.

Phillips CJ, Woolpert T, Sevick C, Faix D, Blair PJ, Crum-Cianflone NF.

Clin Infect Dis. 2013 Jan;56(1):11-9. doi: 10.1093/cid/cis860. Epub 2012 Nov 26.

PMID:
23183869
2.

Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.

Wang Z, Tobler S, Roayaei J, Eick A.

JAMA. 2009 Mar 4;301(9):945-53. doi: 10.1001/jama.2009.265. Epub 2009 Mar 2.

PMID:
19255113
3.

Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, Vest KG, Russell KL, DeFraites RF, Sanchez JL.

PLoS One. 2010 May 19;5(5):e10722. doi: 10.1371/journal.pone.0010722.

4.

Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members.

Eick AA, Wang Z, Hughes H, Ford SM, Tobler SK.

Vaccine. 2009 Jun 2;27(27):3568-75. doi: 10.1016/j.vaccine.2009.03.088. Epub 2009 Apr 19.

PMID:
19464536
5.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group..

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
6.

Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach.

Eick-Cost AA, Tastad KJ, Guerrero AC, Johns MC, Lee SE, Macintosh VH, Burke RL, Blazes DL, Russell KL, Sanchez JL.

PLoS One. 2012;7(7):e41435. doi: 10.1371/journal.pone.0041435. Epub 2012 Jul 31.

7.

Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.

Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, Pebody R.

Vaccine. 2012 Feb 8;30(7):1371-8. doi: 10.1016/j.vaccine.2011.12.038. Epub 2011 Dec 16.

PMID:
22178524
8.

Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.

Nohynek H, Baum U, Syrjänen R, Ikonen N, Sundman J, Jokinen J.

Euro Surveill. 2016 Sep 22;21(38). doi: 10.2807/1560-7917.ES.2016.21.38.30346.

9.

Health-related behaviors and effectiveness of trivalent inactivated versus live attenuated influenza vaccine in preventing influenza-like illness among young adults.

Woolpert T, Phillips CJ, Sevick C, Crum-Cianflone NF, Blair PJ, Faix D.

PLoS One. 2014 Jul 11;9(7):e102154. doi: 10.1371/journal.pone.0102154. eCollection 2014.

10.

Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.

Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA.

J Infect Dis. 2013 Apr 15;207(8):1262-9. doi: 10.1093/infdis/jit020. Epub 2013 Jan 22.

PMID:
23341536
11.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group..

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
12.

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T.

PLoS One. 2011 May 10;6(5):e19621. doi: 10.1371/journal.pone.0019621.

13.

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.

Ambrose CS, Wu X, Knuf M, Wutzler P.

Vaccine. 2012 Jan 20;30(5):886-92. doi: 10.1016/j.vaccine.2011.11.104. Epub 2011 Dec 7.

14.

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.

Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, Alvarez N, Arriazu M, Elía F, Salcedo E, Barricarte A; Primary Health Care Sentinel Network of Navarre..

Vaccine. 2011 Aug 11;29(35):5919-24. doi: 10.1016/j.vaccine.2011.06.063. Epub 2011 Jun 30.

PMID:
21723358
15.

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.

Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046. Epub 2008 May 6.

PMID:
18462851
16.

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.

Carter NJ, Curran MP.

Drugs. 2011 Aug 20;71(12):1591-622. doi: 10.2165/11206860-000000000-00000. Review.

PMID:
21861544
17.

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.

Ambrose CS, Levin MJ, Belshe RB.

Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19. Review.

18.

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.

Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.

PMID:
19095024
19.

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.

Mallory RM, Yi T, Ambrose CS.

Vaccine. 2011 Jun 10;29(26):4322-7. doi: 10.1016/j.vaccine.2011.04.022. Epub 2011 Apr 20.

PMID:
21513761
20.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577

Supplemental Content

Support Center